Epidermal growth factor receptor (EGFR) is overexpressed in several epithelial malignancies, including SCCHN, which exhibits EGFR overexpression in up to 90% of tumors (35–37). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.